Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
7
Recruiting, any sponsor type, condition "postpartum depression"
By trial status
The same filters, counted in each status. Pick one to switch.
7 trials
Showing 1 to 7, recently updated first.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoAcademic, hospital or other
NCT06131255 · 15 participants (planned) · Start Aug 1, 2023 · Primary completion Jan 2027
Drug: Citalopram · For: Post-partum Depression
Sites: Milan, Italy
University of UtahAcademic, hospital or other
NCT06767566 · 50 participants (planned) · Start Apr 30, 2025 · Primary completion Dec 7, 2027
Drug: Ketamine (Ketalar) · For: Pain; Postpartum Depression
Sites: Pittsburgh, Pennsylvania; Salt Lake City, Utah
- Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum DepressionPivotal-lookingRecruiting
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT06833788 · 2,860 participants (planned) · Start Oct 22, 2025 · Primary completion Jun 22, 2028
Drug: Ferric carboxymaltose IV; TIMOFÉROL® · For: Postpartum Depression (PPD)
Sites: Paris, France
- Brexanolone Lifting Outcomes Of MomsPivotal-lookingRecruiting
Lipocine Inc.Industry
NCT07822321 · 120 participants (planned) · Start Sep 2026 · Primary completion Aug 2027
Drug: LPCN 1154A; Placebo · For: Depression, Postpartum; Postpartum Depression (PPD); Post-partum Depression and 3 more
Sites: Tucson, Arizona; Canoga Park, California; Walnut Creek, California · 16 sites in all
BiogenBiogen (BIIB)
NCT07398469 · 300 participants (planned) · Start Dec 22, 2025 · Primary completion Mar 29, 2027
Drug: Zuranolone · For: Postpartum Depression
Sites: Cambridge, Massachusetts
- A Study of MI078 for Postpartum DepressionPivotal-lookingRecruiting
Nanjing Minova Pharmaceutical Co., Ltd.Industry
NCT07721961 · 200 participants (planned) · Start Jul 10, 2026 · Primary completion Dec 2027
Drug: MI078 capsule; Placebo of MI078 capsules · For: Postpartum Depression (PPD)
Sites: Hefei, China; Chongqing, China; Xiamen, China · 36 sites in all
- Maternal Mental Health TrialPivotal-lookingRecruiting
Vibe G Frøkjær, MD, PhDAcademic, hospital or other
NCT04685148 · 220 participants (planned) · Start Feb 3, 2021 · Primary completion Dec 31, 2026
Drug: Transdermal patch estradiol; Transdermal patch placebo · For: Major Depressive Disorder; Postpartum Depression
Sites: Copenhagen, Denmark
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.